A PHASE IIIb OPEN-LABEL, SINGLE-ARM STUDY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TO EVALUATE THE USABILITY OF RANIBIZUMAB 10 mg/0.1 mL PREFILLED SYRINGE WITH THE PORT DELIVERY SYSTEM
Research Grant
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
June 11, 2020
End Date
April 23, 2021
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
June 11, 2020
End Date
April 23, 2021